Cytokinetics CYTK CA — Operating Lease Liability Current
Discontinued — last reported Q1 '22
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Cytokinetics’s 10-Q, filed May 6, 2022, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's ca — operating lease liability current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytokinetics's CA — operating lease liability current?
- Cytokinetics (CYTK) reported CA — operating lease liability current of $3.7M in Q1 2022.
- What does CA — operating lease liability current mean?
- The amount of lease payments due within one year for this segment.
- How do you interpret CA — operating lease liability current?
- An increase suggests higher short-term cash commitments for facility or equipment rentals.
- How does CA — operating lease liability current compare across companies?
- Standard current liability disclosure for all companies with significant operating leases.